News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Sustainability

Latest News

November 16th 2020
Synthetic Biology and the Environment
By Sandor Schoichet

SynBio opens new environmental sustainability possibilities for pharma.

November 16th 2020

Measuring Pharma’s Wider Mandate

By Pamela Spence
October 14th 2020

The Regulatory Engagement Conundrum

By Sandor Schoichet
September 11th 2020

Sustainable Long-Term Planning

By Sandor Schoichet
August 7th 2020

Pharma’s Digital-Trust Mandate

By Sandor Schoichet
Advertisement

Advertisement

A Sustainable Response to COVID-19

BySandor Schoichet
July 7th 2020

Three areas critical to ensuring meaningful long-term action.

sustainability.png

Better ESG Communication with Investors

BySandor Schoichet
June 12th 2020

Guidance addresses struggles in reporting non-financial performance.

Sandor Schoichet.jpg

Biopharma Sustainability Considered Essential

BySandor Schoichet
May 18th 2020

The commercial and social value of non-financial performance.

  • Prev
  • 1
  • 2
  • Prev
Advertisement
Advertisement

Trending on PharmExec

1

Johnson and Johnson Reveals Plan to Separate Orthopaedics Business

2

Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil

3

The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.

4

Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity

5

Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us